Smiling man getting treatment

Special Dialyzers

State-of-the art membrane designs supporting all patient needs

Polyflux 2H and 6H Dialyzers

Specialized for low-body-weight patients

 

Nephral ST Dialyzer

Features a heparin adsorptive hydrogel membrane for a reduced use of heparin during dialysis

Evodial Dialyzer

Specialized for patients with a high risk of bleeding1,2

 

Theralite Dialyzer

Created for multiple myeloma patients requiring hemodialysis treatments

Advanced dialyzers that empower patients and healthcare providers alike

Each dialyzer features a unique membrane tailored to specific therapy and patient population needs and benefits from Vantive’s long history of expertise in performance, quality and simplicity. Vantive is committed to helping providers achieve the best possible outcomes for both at-home and in-center dialysis patients and provides the tools to do so.

Download brochure

Polyflux 2H and 6H Dialyzers

Specialized for patients of low body weight, the Polyflux 2H and 6H dialyzers feature a unique Polyamix membrane that enables high-flux dialysis compatibility and performance for patients of low body weight, typically children.3-5

For more information on Polyflux 2H and 6H, consult the Polyflux 2H and 6H datasheet.

Download datasheet
Polyflux 2H and 6H dialyzers
Download datasheet

Nephral ST Dialyzer

The Nephral ST Dialyzer series features a heparin adsorptive hydrogel membrane for reduced use of heparin during dialysis. The membrane is designed to provide effective removal of uremic toxins and inflammatory mediators6 while also reducing the systemic use of heparin. It may be an alternative for patients with hypersensitivity to conventional membranes.7 

For more information on how the Nephral ST Dialyzer series can improve outcomes for patients, consult the Nephral ST datasheet.

Download datasheet
specialDialyzer
Download datasheet

Evodial Dialyzer

Specialized for patients at high risk of bleeding,1,2 the Evodial Dialyzer series has been designed with a HeprAN heparin-grafted membrane6,8 and provides a convenient solution for patients requiring reduced or even heparin-free dialysis. 

For more information on how the Evodial Dialyzer series can expand treatment options for patients with high bleeding risk, consult the Evodial Dialyzer datasheet.

Download datasheet
Evodial Dialyzers
Download datasheet

Theralite Dialyzer

Created for multiple myeloma patients requiring hemodialysis treatments, the Theralite Dialyzer’s proprietary high cut-off (HCO) membrane targets the removal of the free light chain (FLC) proteins that are overproduced in patients with multiple myeloma and cause renal failure.9,10 

To learn more about what the Theralite Dialyzer series can do for patients with multiple myeloma, consult the Theralite Dialyzer datasheet.

Download datasheet
3.2.6_specialDialyzer_coreStoreElement
Download datasheet

Related products

Important Safety Information

Polyflux 2H – Indications/Intended Use: The Polyflux 2 H is indicated for treatment of chronic and acute renal failure by hemodialysis, hemodiafiltration and hemofiltration.

Polyflux 6H - Indications/Intended Use: Polyflux 6 H is intended for chronic and acute applications in hemodialysis, hemodiafiltration and hemofiltration on small patients including pediatric indications, considering blood flow, body weight and extracorporeal blood volume. 

Nephral ST – Intended Use/Purpose: Nephral ST hemodialyzers/diafilters/filters (“devices” throughout the text) are intended to purify blood in hemodialysis, hemodiafiltration and hemofiltration. Indication: Nephral ST devices are indicated for the treatment of chronic renal failure. 

Evodial – Intended Use/Purpose: Evodial hemodialyzers/diafilters/filters (“devices” throughout the text) are intended to purify blood in hemodialysis, hemodiafiltration and hemofiltration. Indication: Evodial devices are indicated for the treatment of chronic or acute renal failure.

Theralite - Indications: Theralite dialyzer is only intended to be used for blood purification in hemodialysis mode in diseases where re[1]moval of plasma components with molecular weights up to a value of 45 kDa is indicated. 

Revaclear Dialyzer – Intended Use/Purpose: Revaclear hemodialyzers/diafilters (“device” throughout the text) are intended to purify blood in hemodialysis and hemodiafiltration. Indication: Revaclear devices are indicated for the treatment of chronic or acute renal failure.

Polyflux L Dialyzer – Indications: The capillary dialyzer is intended for use in hemodialysis, for the treatment of chronic or acute renal failure.

Polyflux H Dialyzer – Indications: The capillary dialyzer/filter is intended for use in hemodialysis, hemodiafiltration and hemofiltration for the treatment of chronic or acute renal failure.

For safe and proper use of the devices, please refer to the Instructions for Use.

Vantive, Evodial, Nephral, Polyamix, Polyflux and Theralite are trademarks of Vantive Health LLC or its affiliates.

References

  1. Laville M, Dorval M, Fort Ros J, et al. Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis.. Kidney Int. 2014; 86:1260-1267.

  2. Kessler M, Moureau F, Nguyen P, et al. Anticoagulation in chronic hemodialysis: progress toward an optimal approach. Semin Dial. 2015; 28:474-489.

  3. Ronco C, Crepaldi C, Brendolan A, et al. Evolution of synthetic membranes for blood purification: the case of the Polyflux family. Nephrol Dial Transplant. 2003;18(7):vii10-20.

  4. Goldstein SL, Allsteadt A, Beck W, Nilsson L-G.  Evaluation of the Polyflux® 6H Dialyzer in pediatric patients receiving maintenance hemodialysis. Int J Artif Organs. 2007;30:321-324.

  5. Warady BA, et al. Maintenance hemodialysis during infancy. Pediatric Dialysis. Chapter 19. 2012. Edited by Ulinski T, Cochat P.

  6. Thomas M, Moriyama K, Ledebo I. AN69: Evolution of the world's first high permeability membrane. Contrib Nephrol. 2011;173:119-129.

  7. Bouman CS, van Olden RW, Stoutenbeek CP. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif. 1998;16:261-268.

  8. Chanard J, Lavaud S, Maheut H, et al. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane. Nephrol Dial Transplant. 2008;23:2003-2009.

  9. Boschetti-de-Fierro A, Voigt M, Storr M, Krause B. Extended characterization of a new class of membranes for blood purification: the high cut-off membranes. Int J Artif Organs. 2013;36:455-463.

  10. Hutchison CA, Batuman V, Behrens J, et al. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol. 2012;8:43-51.